Sort
23,748 grants matching “melanoma”
Targeting HSP70 in autoimmune vitiligo
$314,447Isabelle Caroline Le Poole · Loyola University Chicago · R01 · FY2011 · AR
Melanoma Vaccines with Peptides, Protein and Adjuvant
$314,446Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · CA
Cellular Interactions with the Extracellular Matrix of the Tumor Microenvironment
$314,441Richard O Hynes · Massachusetts Institute Of Technology · U54 · FY2007 · CA
Somatic genetic predictors of response to therapy in metastatic melanoma
$314,405Katherine L Nathanson · University Of Pennsylvania · R01 · FY2008 · CA
Reversing melanoma-induced T cell dysfunction
$314,363Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · CA
Role of CXCR3 for CD8+ T cells in cancer immunotherapy
$314,363David W. Mullins · University Of Virginia · R01 · FY2009 · CA
Reversing melanoma-induced T cell dysfunction
$314,363Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · CA
Role of CXCR3 for CD8+ T cells in cancer immunotherapy
$314,363David W. Mullins · University Of Virginia · R01 · FY2010 · CA
Epigenetic and post-translational regulation of the metastasis suppressor BRMS1
$314,363David R Jones · University Of Virginia · R01 · FY2010 · CA
Reversing melanoma-induced T cell dysfunction
$314,363Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · CA
Interferon-gamma limits the effectiveness of peptide vaccines for cancer
$314,363Esteban Celis · Augusta University · R01 · FY2015 · CA
Protease Activated Receptors in Cancer Invasion
$314,360Lidija Covic · Tufts Medical Center · R01 · FY2006 · CA
SOUTHWEST ONCOLOGY GROUP
$314,340Louisiana State Univ Hsc Shreveport · U10 · FY2003 · CA
Developmental Core
$314,321Warren Jackson Pledger · H. Lee Moffitt Cancer Ctr & Res Inst · U56 · FY2009 · CA
Immunization Against Melanoma Differentiation Antigens
$314,300Jedd D. Wolchok · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Defining the Role of BPTF Epigenetic Reader Domains in Cancer
$314,246William Charles Krause Pomerantz · University Of Minnesota · R01 · FY2018 · GM
Project 3: Notch signaling in oHSV therapy for GBM
$314,231Balveen Kaur · Brigham And Women'S Hospital · P01 · FY2022 · CA
In-situ activation of antitumor effectors
$314,200Edmund C. Lattime · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2008 · CA
A Study of Telomeres in an Arsenic-Exposed Bangladesh Cohort
$314,195Brandon Lee Pierce · University Of Chicago · R01 · FY2014 · ES
Somatic genetic predictors of response to therapy in metastatic melanoma
$314,179Katherine L Nathanson · University Of Pennsylvania · R01 · FY2007 · CA
Role of SIRT1 in melanocyte biology and melanocyte transformation
$314,176Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2015 · CA
Role of SIRT1 in melanocyte biology and melanocyte transformation
$314,176Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2016 · CA
ASSESSING THE THERAPEUTIC WINDOW FOR FUTURE ANTI-NOTCH DIMERIZATION AGENTS
$314,149Raphael Kopan · Cincinnati Childrens Hosp Med Ctr · R01 · FY2014 · CA
IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems
$314,104Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Core C: Cell Biology Core
$314,103Meenhard Herlyn · Wistar Institute · P01 · FY2017 · CA